Journal rankings · indicator year 2008
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2008
Immunology journal rankings 2008
71 ranked journals · Subfield in Immunology and Microbiology
Immunology has 71 ranked journals in 2008. The median journal has an OJR of 1.00, level with the world average of 1.00, up 0.04 on 2007; Q1 starts at OJR 1.34. The top three are Nature Immunology, Immunity, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2008. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2005–2007, the window the 2008 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
71 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2007. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2005–2007, the window the 2008 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2005–2007 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2008. | Compare |
|---|---|---|---|---|---|---|---|
1Nature ImmunologyNature Portfolio · United States | 5.88Q1 | 16.25 1.46 down from 2007 | 682 | 42% | $12,690 | ||
2ImmunityCell Press · United States | 5.09Q1 | 16.53 0.98 up from 2007 | 550 | 100% | $10,400 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 4.62Q1 | 13.33 0.79 down from 2007 | 1,204 | 93% | — | ||
4Seminars in ImmunologyElsevier BV · United States | 2.93Q1 | 10.46 3.14 up from 2007 | 138 | 50% | $4,370 | ||
5Annual Review of ImmunologyAnnual Reviews · United States | 2.84Q1 | 39.47 7.27 down from 2007 | 68 | 35% | — | ||
6Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.72Q1 | 8.08 1.18 up from 2007 | 1,538 | 51% | $4,900 | ||
7Journal of AutoimmunityElsevier BV · United Kingdom | 2.01Q1 | 7.82 2.44 up from 2007 | 241 | 31% | $5,420 | ||
8The AAPS JournalSpringer Science+Business Media · United States | 2.00Q1 | 5.08 0.98 up from 2007 | 246 | 93% | $5,090 | ||
9The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.97Q1 | 6.31 0.24 down from 2007 | 6,035 | 67% | $3,500 | ||
10Seminars in ImmunopathologySpringer Science+Business Media · Germany | 1.88Q1 | 4.36 4.36 up from 2007 | 43 | 32% | $3,790 | ||
11Springer Seminars in ImmunopathologySpringer Science+Business Media · Germany | 1.73Q1 | 5.18 0.87 up from 2007 | 77 | — | — | ||
12Nature reviews. ImmunologyNature Portfolio · United Kingdom | 1.70Q1 | 13.12 0.72 up from 2007 | 668 | 17% | — | ||
13Genes and ImmunitySpringer Nature · United States | 1.70Q1 | 4.90 0.29 up from 2007 | 286 | 36% | $3,190 | ||
14Journal of Leukocyte BiologyOxford University Press · United States | 1.60Q1 | 4.74 0.18 up from 2007 | 990 | 40% | $3,800 | ||
15European Journal of ImmunologyWiley · Germany | 1.57Q1 | 4.93 0.12 up from 2007 | 1,125 | 69% | $4,550 | ||
16International Reviews of ImmunologyTaylor & Francis · United States | 1.51Q1 | 6.10 1.70 up from 2007 | 59 | 12% | — | ||
17Critical Reviews in ImmunologyBegell House · United States | 1.49Q1 | 3.90 0.76 down from 2007 | 84 | 12% | — | ||
18Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.34Q1 | 3.91 0.79 up from 2007 | 426 | 12% | — | ||
19Clinical ImmunologyElsevier BV · Netherlands | 1.34Q2 | 3.98 0.84 up from 2007 | 500 | 10% | $4,400 | ||
20BioDrugsAdis, Springer Healthcare · Switzerland | 1.32Q2 | 2.90 0.06 down from 2007 | 123 | 5% | $5,190 | ||
21Immunity & AgeingOABioMed Central · United Kingdom | 1.32Q2 | 3.57 0.05 up from 2007 | 38 | 100% | $3,190 | ||
22Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.29Q2 | 3.63 0.37 up from 2007 | 222 | 18% | $4,990 | ||
23Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.29Q2 | 3.07 0.33 up from 2007 | 59 | 0% | — | ||
24Immunology and Cell BiologyWiley · Australia | 1.27Q2 | 3.77 0.68 up from 2007 | 308 | 44% | $3,750 | ||
25ImmunobiologyOAElsevier BV · Germany | 1.27Q2 | 3.92 0.88 up from 2007 | 252 | 21% | $2,840 | ||
26Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.23Q2 | 3.60 0.51 up from 2007 | 835 | 89% | $3,816 | ||
27BMC ImmunologyOABioMed Central · United Kingdom | 1.22Q2 | 3.28 0.25 up from 2007 | 84 | 100% | $3,090 | ||
28ImmunologyWiley · United Kingdom | 1.18Q2 | 3.40 0.30 up from 2007 | 639 | 86% | $5,330 | ||
29Molecular ImmunologyElsevier BV · Netherlands | 1.16Q2 | 3.39 0.38 up from 2007 | 936 | 16% | $3,340 | ||
30Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 1.13Q2 | 7.12 4.81 down from 2007 | 160 | 40% | $4,900 | ||
31Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 1.12Q2 | 3.44 0.46 up from 2007 | 194 | 11% | $5,490 | ||
32International ImmunologyOxford University Press · United Kingdom | 1.12Q2 | 3.57 0.44 up from 2007 | 478 | 38% | $3,530 | ||
33CytokineElsevier BV · United Kingdom | 1.05Q2 | 2.64 0.21 up from 2007 | 454 | 8% | $3,220 | ||
34Immunology LettersElsevier BV · Netherlands | 1.02Q2 | 3.08 0.36 up from 2007 | 435 | 24% | $3,290 | ||
35Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 1.01Q2 | 3.20 0.33 up from 2007 | 321 | 20% | $3,340 | ||
36Human ImmunologyElsevier BV · United States | 1.00Q2 | 3.25 0.37 up from 2007 | 409 | 6% | $3,600 | ||
37Immunologic ResearchSpringer Science+Business Media · United States | 1.00Q3 | 2.71 0.21 down from 2007 | 230 | 42% | $2,890 | ||
38ImmunogeneticsSpringer Science+Business Media · Germany | 0.96Q3 | 3.37 0.42 up from 2007 | 318 | 40% | $2,890 | ||
39Toxicologic PathologySAGE Publishing · United States | 0.94Q3 | 2.08 0.31 down from 2007 | 317 | 27% | $4,150 | ||
40Journal of Immunological MethodsElsevier BV · Netherlands | 0.93Q3 | 2.44 0.29 up from 2007 | 631 | 19% | $2,970 | ||
41Journal of Reproductive ImmunologyElsevier BV · Netherlands | 0.90Q3 | 2.15 0.42 down from 2007 | 242 | 21% | $3,690 | ||
42Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 0.88Q3 | 2.26 0.57 up from 2007 | 108 | 11% | $3,490 | ||
43Journal of Endotoxin ResearchManey Publishing · United Kingdom | 0.88Q3 | 2.54 0.43 down from 2007 | 221 | — | — | ||
44Veterinary Immunology and ImmunopathologyElsevier BV · Netherlands | 0.86Q3 | 2.26 0.06 up from 2007 | 634 | 17% | $3,250 | ||
45Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.84Q3 | 1.70 1.05 down from 2007 | 293 | 20% | — | ||
46American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.84Q3 | 2.36 0.08 up from 2007 | 309 | 17% | $4,460 | ||
47Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.82Q3 | 2.33 0.31 up from 2007 | 505 | 63% | $4,480 | ||
48Trends in ImmunologyElsevier BV · United Kingdom | 0.81Q3 | 9.93 0.28 down from 2007 | 292 | 26% | $7,030 | ||
49Cellular ImmunologyElsevier BV · Netherlands | 0.80Q3 | 2.50 0.45 up from 2007 | 283 | 26% | $3,550 | ||
50Immunological ReviewsWiley · United States | 0.78Q3 | 13.65 1.29 up from 2007 | 354 | 34% | $5,000 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2008. Corpus-wide, 71.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
19 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2005–2007, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2008. Publication window: 2005–2007. How these summaries are calculated
- Ranked journals
- 71
- Window papers (baseline)
- 53,923 +20.2% from indicator year 2005
- Median OJR
- 1.002 +14.4% from indicator year 2005
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2005–2007 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.